You are here
GBT Announces Participation at Upcoming Investor Conferences in March
SOUTH SAN FRANCISCO, Calif., March 05, 2018 (GLOBE NEWSWIRE) -- Global Blood Therapeutics, Inc. (GBT) (NASDAQ:GBT) today announced that it will present at the following investor conferences in March 2018:
- Cowen and Company 38th Annual Health Care Conference in Boston on March 12 at 11:20 a.m. Eastern Time (ET);
- 28th Annual Oppenheimer Healthcare Conference in New York City on March 20 at 10:55 a.m. ET; and
- 17th Annual Needham Healthcare Conference in New York City on March 27 at 11:30 a.m. ET.
GBT is a clinical-stage biopharmaceutical company determined to discover, develop and deliver innovative treatments that provide hope to underserved patient communities. GBT is developing its lead product candidate, voxelotor, as an oral, once-daily therapy for sickle cell disease. To learn more, please visit www.gbt.com and follow the company on Twitter @GBT_news.
Myesha Lacy (investors)
Julie Normart (media)